It has also been reported that elevated serum FABP4 concentration is associated with obesity, insulin resistance, type 2 diabetes mellitus, hypertension, cardiac dysfunction, renal dysfunction, dyslipidemia, atherosclerosis and cardiovascular events [13, 23–34]. Here, FABP4 is linked to metabolic syndrome.